Medicinova (MNOV) Cash from Financing Activities (2010 - 2021)

Medicinova (MNOV) has reported Cash from Financing Activities for 12 consecutive years, with $38699.0 the latest figure, recorded in Q4 2021.

• In Q4 2021, Cash from Financing Activities fell 89.21% year-over-year to $38699.0; the TTM figure through Dec 2022 stood at $288310.0 (down 98.61% YoY), while the FY2025 annual figure was $244018.0, changed N/A from the prior year.
• Cash from Financing Activities fell to $38699.0 in Q4 2021 per MNOV's latest filing, from $249611.0 in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $39.0 million in Q1 2018 and bottomed at $15178.0 in Q3 2018.
• Historically, Cash from Financing Activities has averaged $4.6 million across 5 years, with a median of $1.9 million in 2018.
• On a YoY basis, Cash from Financing Activities climbed as much as 58903.13% in 2018 and fell as far as 99.57% in 2018.
• Medicinova's Cash from Financing Activities stood at $4.5 million in 2017, then sank by 66.35% to $1.5 million in 2018, then surged by 119.87% to $3.3 million in 2019, then sank by 89.23% to $358650.0 in 2020, then tumbled by 89.21% to $38699.0 in 2021.
• Business Quant data shows MNOV's Cash from Financing Activities at $38699.0 in Q4 2021, $249611.0 in Q3 2021, and $389738.0 in Q2 2021.